Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate
- PMID: 3931732
- PMCID: PMC1916706
- DOI: 10.1111/j.1476-5381.1985.tb08911.x
Oxidative transformations of arachidonic acid in human dispersed lung cells: disparity between the utilization of endogenous and exogenous substrate
Abstract
Eicosanoid release from human dispersed lung cells (HDLC) containing ca 5% mast cells was studied before and after cell activation with ionophore A23187 or anti-IgE. Basal release of eicosanoids synthesized from endogenous arachidonate was measured by radioimmunoassay. In descending order of abundance the products were: 5-hydroxyeicosatetraenoic acid (5-HETE) greater than thromboxane B2 (TXB2) greater than prostaglandin F2 alpha (PGF2 alpha) approximately immunoreactive (i)-PGE2 greater than PGD2 greater than 6-keto-PGF1 alpha approximately i-LTC4. Stimulation of HDLC with ionophore A23187 or, after passive sensitization, with anti-IgE resulted in 2-10 fold increases in the generation of individual eicosanoids. In terms of net generation the most abundant products were PGD2 and TXB2 with either stimulus. Activation with A23187 caused net release of i-LTC4 and 5-HETE, but these products were not measured after immunological activation. A more complete profile of lipoxygenase products released from HDLC dispersed from one lung was obtained after separation by high performance liquid chromatography combined with ultra violet spectroscopy and bioassay. The major products released from the cells from this lung with ionophore stimulation were 13-hydroxylinoleic acid greater than LTB4 greater than 5-HETE greater than 12-HETE greater than LTC4 greater than 15-HETE greater than 11-HETE approximately 9-HETE. When the utilization of exogenous [14C]-arachidonic acid for prostanoid biosynthesis was compared to that of endogenous unlabelled arachidonate the formation of TXB2 was consistently underestimated. These results imply compartmentalization of arachidonic acid utilization in Ca2+-activated HDLC. In unstimulated cells the proportional formation of PGD2 was overestimated when exogenous arachidonic acid was substrate. After activation with A23187 the proportions of PGD2 were similar with both substrate sources. The large proportions of PGD2 and TXB2 generated by HDLC further supports the view that these eicosanoids may be important inflammatory mediators in lung tissue.
Similar articles
-
Ionophore-dependent generation of eicosanoids in human dispersed lung cells. Modulation by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60,257).Biochem Pharmacol. 1986 Jun 1;35(11):1903-8. doi: 10.1016/0006-2952(86)90310-2. Biochem Pharmacol. 1986. PMID: 3087365
-
Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.J Immunol. 1984 Oct;133(4):2138-44. J Immunol. 1984. PMID: 6206153
-
Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung.Br J Pharmacol. 1985 Sep;86(1):55-62. doi: 10.1111/j.1476-5381.1985.tb09434.x. Br J Pharmacol. 1985. PMID: 2996675 Free PMC article.
-
Complement-mediated arachidonate metabolism.Prog Biochem Pharmacol. 1985;20:120-31. Prog Biochem Pharmacol. 1985. PMID: 2986155 Review.
-
The generation of prostaglandins by human lung and their effects on airway function in man.Bull Eur Physiopathol Respir. 1986;22 Suppl 7:81-90. Bull Eur Physiopathol Respir. 1986. PMID: 3513876 Review.
Cited by
-
Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma.Thorax. 1986 Oct;41(10):746-52. doi: 10.1136/thx.41.10.746. Thorax. 1986. PMID: 3538476 Free PMC article. Clinical Trial.
-
Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.Thorax. 1987 Dec;42(12):946-52. doi: 10.1136/thx.42.12.946. Thorax. 1987. PMID: 2894081 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous